<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03134053</url>
  </required_header>
  <id_info>
    <org_study_id>16MMHIS025e</org_study_id>
    <nct_id>NCT03134053</nct_id>
  </id_info>
  <brief_title>Effect of Extracorporeal Shock Waves on Hypertrophy Scar</brief_title>
  <official_title>Assessment of the Effect of Extracorporeal Shock Waves on Hypertrophy Scar</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mackay Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mackay Memorial Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the effect of extracorporeal shock waves on hypertrophy scar&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prolonged and abnormal scarring after trauma, burns and surgical procedures often results in&#xD;
      functional and cosmetic deformities. A wide variety of treatments have been advocated for&#xD;
      pathologic scars regression. Unfortunately, the reported efficacy has been variable.Unfocused&#xD;
      extracorporeal shock wave therapy is a feasible and non-intensive treatment. And it is an&#xD;
      emerging option for the treatment of painful and retracting scars.&#xD;
&#xD;
      Administration of ESWT appears to result in significant improvements in scar clinical&#xD;
      appearance, mobility and subjective pain. Clinical data were mirrored by histologic changes&#xD;
      in connective tissue appearance and scar vascularization. Extracorporeal shock wave therapy&#xD;
      is also an effective and conservative treatment for patients with aesthetic and functional&#xD;
      sequela from burn scars. It is a feasible, cost-effective, well-tolerated treatment that can&#xD;
      be used in the management of post-burn pathologic scars after the patients are briefed on the&#xD;
      practical aspects of the treatment procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">October 1, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline thick of scar</measure>
    <time_frame>immediately post intervention, 1 month after, and 3 months</time_frame>
    <description>sonography for thick of scar</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change from baseline Modified Vancouver Scar Scale</measure>
    <time_frame>immediately post intervention, 1 month after, and 3 months</time_frame>
    <description>questionnaires of Modified Vancouver Scar Scale for scar measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline Visual analogue scores (VAS)</measure>
    <time_frame>immediately post intervention, 1 month after, and 3 months</time_frame>
    <description>Visual analogue scores (VAS) for pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline skin color</measure>
    <time_frame>immediately post intervention, 1 month after, and 3 months</time_frame>
    <description>DermaLab Combo series for skin color</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline Patient Scar Assessment Scale (POSAS)</measure>
    <time_frame>immediately post intervention, 1 month after, and 3 months</time_frame>
    <description>questionnaires of Patient Scar Assessment Scale (POSAS) for scar measure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Hypertrophy; Scar</condition>
  <arm_group>
    <arm_group_label>extracorporeal shock-wave</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>massage</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>extracorporeal shock-wave</intervention_name>
    <description>to treat painful and retracting scars</description>
    <arm_group_label>extracorporeal shock-wave</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>massage</intervention_name>
    <description>to treat painful and retracting scars</description>
    <arm_group_label>massage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. aged between 18 ~ 65 years old;&#xD;
&#xD;
          2. at least 4 weeks since onset of onset of wound;&#xD;
&#xD;
          3. healing wound with at least 6 scores in Modified Vancouver Scar Scale for more than&#xD;
             four weeks&#xD;
&#xD;
          4. the most important of all, read and signed the inform concern of this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. patients with open wound;&#xD;
&#xD;
          2. oxygen dependent&#xD;
&#xD;
          3. having evidence of cognitive deficit;&#xD;
&#xD;
          4. having local infection, severe inflammation or otherwise lesion that is not suggestive&#xD;
             for ESWT;&#xD;
&#xD;
          5. patient with serious medical problems, as uncontrolled hypertension, coagulopathy,&#xD;
             recent severe hemorrhage, neoplasm, severe hepatic disease, epilepsy, cutaneous&#xD;
             pathology, mental retardation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Li-Ru Chen, MD</last_name>
    <phone>886-2-2543-3535</phone>
    <email>gracealex168@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mackay Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>104</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <last_name>Li-Ru Chen, MD</last_name>
      <email>gracealex168@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Li-Ru Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2017</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mackay Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Li-Ru Chen,MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>hypertrophy scar</keyword>
  <keyword>burn</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

